Black Rock Inc. X Biotech Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in X Biotech Inc. stock. As of the latest transaction made, Black Rock Inc. holds 306,624 shares of XBIT stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

306,624

Previous 278,159 10.23%

Holding current value

$1.58 Million

Previous $1.11 Million 124.1%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.03 - $8.13 $114,713 - $231,420	28,465 Added 10.23%	306,624 $2.49 Million
Q4 2023 Feb 13, 2024	SELL	$3.56 - $4.65 $2,406 - $3,143	-676 Reduced 0.24%	278,159 $1.11 Million
Q3 2023 Nov 13, 2023	SELL	$4.02 - $5.81 $44,268 - $63,979	-11,012 Reduced 3.8%	278,835 $1.15 Million
Q2 2023 Aug 11, 2023	BUY	$3.06 - $6.38 $84,612 - $176,413	27,651 Added 10.55%	289,847 $1.72 Million
Q1 2023 May 12, 2023	BUY	$3.22 - $4.72 $3,203 - $4,696	995 Added 0.38%	262,196 $904,000

Q4 2022 Feb 13, 2023	BUY	$3.03 - $3.64 $6,869 - $8,251	2,267 Added 0.88%	261,201 $916,000
Q3 2022 Nov 14, 2022	BUY	$3.72 - $5.88 $14,887 - $23,531	4,002 Added 1.57%	258,934 $938,000
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $3.97 Million - $7.12 Million	-774,178 Reduced 75.23%	254,932 $1.44 Million
Q1 2022 May 12, 2022	SELL	$8.64 - $11.71 $230,394 - $312,258	-26,666 Reduced 2.53%	1,029,110 $8.89 Million
Q4 2021 Feb 10, 2022	SELL	$10.95 - $16.07 $1.84 Million - $2.7 Million	-167,878 Reduced 13.72%	1,055,776 $11.8 Million
Q3 2021 Nov 09, 2021	BUY	$12.95 - $18.24 $285,638 - $402,319	22,057 Added 1.84%	1,223,654 $15.8 Million
Q2 2021 Aug 11, 2021	BUY	$15.83 - $17.84 $19 Million - $21.4 Million	1,201,597 New	1,201,597 $19.9 Million

Others Institutions Holding XBIT

# of Institutions

Shares Held

3.96M

Call Options Held

6.3K

Put Options Held

1.7K

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $156M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account